Mon, Jan 26, 2015, 8:51 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

  • willtrp willtrp Nov 5, 2009 1:58 PM Flag

    Terrific new biotech offering, ACTC

    This company's products are on the cutting edge of medical technology in several key areas poised to enjoy spectacular growth, ACTC. Vivikor, Inc. (VIVK), is a fully reporting Bulletin Board stock that just began trading publicly a couple of months ago. The company's products are on the cutting edge of medical technology in several key areas expected to enjoy spectacular growth. The company's Vivathermic products, for example, are designed to improve cryopreservation of sensitive biological material such as stem cells, including the temperature conductive vials, CryoKeeper and CryoCarrier. Sales could skyrocket as the laboratory bioconsumables market realizes the advantages of this innovative product line. Another division, VivaSight technology, has developed equipment and software technology that modernizes child vision screening. With the anticipated legislative mandating of pediatric vision screening, demand for these products is high and will continue to grow. Yet another division has developed a software upgrade to older MRI units that allows computed tomography to achieve higher resolution using a patented algorithm - thus sparing hospitals and clinics the enormous expense of replacing their MRI units. Vivakor could be a rare ground floor opportunity in the biotech industry.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACTC
6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Microsoft Corporation
NASDAQMon, Jan 26, 2015 4:00 PM EST
Box, Inc.
NYSEMon, Jan 26, 2015 4:01 PM EST